Criteria for onset critically influence the estimation of familial risk in Alzheimer's disease

John C.S. Breitner, Kathryn M. Magruder-Habib

Research output: Contribution to journalArticlepeer-review

Abstract

The rare early-onset variant of Alzheimer's disease (AD) appears to be transmitted as an autosomal dominant genetic trait. More typical late-onset AD also shows familial aggregation, but possible genetic mechanisms are difficult to examine because the phenotypic expression of the putative AD genotype is often censored by prior death from competing causes. Lifetable methods have been used to examine the age-specific risk of dementia among relatives, and thus to test the hypothesis of genetic transmission of late-onset AD. These methods require the ascertainment of affected relatives and the determination of their age at onset. The latter determination is somewhat arbitrary, since symptoms of AD evolve and develop in a continuous and progressive fashion, and different workers may thus use differing criteria for “onset.” This paper demonstrates that the use of divergent thresholds for “caseness” (typically, progressive dementia of several years' duration) and onset (e.g., the first appearance of mild cognitive symptoms, or the first clear evidence of dementia) can introduce substantial bias toward underestimation of risk among relatives. Depending on the definition of onset, familial risk may be underestimated, with apparent cumulative incidence decreased to only 60% of values otherwise expected. We suggest that this problem can be avoided by the use of identical threshold criteria for caseness and for onset.

Original languageEnglish (US)
Pages (from-to)663-669
Number of pages7
JournalGenetic epidemiology
Volume6
Issue number6
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Keywords

  • actuarial analysis
  • genetics
  • medical
  • probability

ASJC Scopus subject areas

  • Epidemiology
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Criteria for onset critically influence the estimation of familial risk in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this